Fraunhofer Institute for Algorithms and Scientific Computing SCAI
Agenda Disease Progression Modeling Workshop
In the following agenda, you will find for each talk a link refering to
- the slide presentation (PDF)
- the talk in a video
Day 1 – April 4th, 2019:
Biomarker - driven progression models in neurodegenerative diseases (AD, PD)
| 09:00 | Welcome Coffee & Registration |
| 10:00 | Martin Hofmann-Apitius Welcome and setting the stage |
| 10:30 | Holger Fröhlich Modeling of Neurodegenerative Disease Risk and Progression |
| 11:00 | Colin Birkenbihl Validation of risk models for AD using independent progression cohort studies |
| 11:30 | Coffee break |
| 12:00 | Bertram Müller-Myhsock Longitudinal modeling and analysis of psychiatry cohort data |
| 12:30 | Stanley Durrleman Longitudinal progression modeling of AD integrating multiscale biomarker data and events |
| 13:00 | Alejo Nevado-Holgado Longitudinal modeling of real-world data: the CRIS data modeling story |
| 13:30 | Lunch Break |
Digital biomarkers - digital signatures (using wearables and sensors to generate signatures on functional domains)
| 14:30 | Emilio Merlo-Pich Setting the scene: the RADAR-AD case; motivation and strategy |
| 15:00 | Meemansa Sood Strategies for the alignment of biomarker progression models with digital signatures |
| 15:30 | Coffee Break |
Visualistics: representation of longitudinal multiscale and multimodal information
| 16:00 | Jörn Kohlhammer Visual analysis of longitudinal clinical data |
| 16:30 | Alex Masny Semantic integration of multimodal, multiscale (progression) information in VirtualBrainCloud |
| 17:00 | Concluding discussion / summary day 1 / preparation for break-out sessions on day 2 |
| 18:00 | Dinner |
Day 2 – April 5th, 2019:
Morning Session: Translational Neuroscience – the bigger picture
| 08:30 | Welcome Coffee |
| 09:00 | Martin Hofmann-Apitius Summary of day 1 and setting the scene for Virtual Cohorts |
| 09:30 | Holger Fröhlich Introducing Longitudinal Virtual Cohorts - a new way of progression modeling, information sharing and simulation |
| 10:00 | Coffee break |
| 10:30 - 12:00 | Break-out Session Group A – Salon Bonn I & II Biomarker progression models and digital biomarkers: Any change to link them? How would we use them for e.g. trial simulation? Group B – Salon Berlin Perspectives for future pre-competitive collaboration: What are our next steps? Where are we going from here? |
| 12:00 | Lunch Discussion |
| 13:00 | Wrap up, conclusion and closure of meeting |
| 14:00 | Departure |